Tagged - URMC
addiction
URMC provides opioid overdose prevention training
Naloxone displaces the opioid from the brain receptors, which stops the effects of the overdose for sixty to ninety minutes. This allows time for a hospital to intervene.
Domestic Violence
The bravery of domestic violence survivors
In honor of domestic violence awareness month in October, Adelante Juntos (translation: “Forward Together”) held their second annual “The Color of Bruises” on Friday, Oct. 25.
Dance
Zumba in medicine, the unexpected crossover
Each year at URMC, a new cohort of unsuspecting pediatrics residents get a crash course. “There are no mistakes in Zumba,” Gellin says.
healthcare
URMC labor unions vote overwhelmingly to strike
The unions representing URMC caregivers and service workers issued on Nov. 30 a 10-day notice for a strike after a nearly-unanimous vote.
Animals
Rest in peace, Med Center bat
Finding a bat in a med center lab raises a lot of questions: How did it get in here? Why did it pick a sticky trap as its landing pad?
labor
Three labor rights allegations brought against URMC
A National Labor Relations Board charge was filed Sept. 13 alleging URMC committed three violations of the National Labor Relations Act.
business
Lean output agreement reached between URMC & LPSA
Lean prices have dropped off steeply over the past month as the LPSA and URMC continued high outputs amid price disagreements while demand rapidly dropped off as consumers fled to ketamine in droves.
premature birth rates
UR Medicine study links redlining in Rochester to premature birth rates
“This is further evidence of the influence of a legacy of structural racism on the disproportionate burden of adverse pregnancy outcomes for Black women in the U.S.,” Hollenbach said in an article published in URMC news.
COVID-19
Prioritizing donors jeopardizes the vaccine rollout
Where else are administrators pulling strings to serve the business side of UR while talking a big game about fairness?
COVID-19
URMC COVID-19 vaccine trials paused
The University of Rochester Medical Center (URMC) is joining hospitals around the world in conducting a phase 3 clinical trial for a potential coronavirus vaccine, known as AZD1222.